Vir Biotechnology, Inc. VIR Grant revenue — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s grant revenue — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s grant revenue — total revenues?
- Vir Biotechnology, Inc. (VIR) reported grant revenue — total revenues of $12K in Q1 2026.
- How has Vir Biotechnology, Inc.'s grant revenue — total revenues changed year-over-year?
- Vir Biotechnology, Inc.'s grant revenue — total revenues decreased by 99.0% year-over-year, from $1.24M to $12K.
- What is the long-term trend for Vir Biotechnology, Inc.'s grant revenue — total revenues?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s grant revenue — total revenues has grown at a -29.7% compound annual growth rate (CAGR), from $8.35M to $2.04M.
- What does grant revenue — total revenues mean?
- This metric represents the proportion of a company's total revenue derived from government or private research grants rather than commercial product sales or service contracts. It serves as an indicator of the company's reliance on non-dilutive funding to support its research and development pipeline. A higher ratio suggests a business model heavily supported by external research subsidies, which may fluctuate based on grant availability and project milestones.